Paper23754276
UV-triggered affinity capture identifies interactions between the Plasmodium falciparum multidrug resistance protein 1 (PfMDR1) and antimalarial agents in live parasitized cells.
Brunner R and 22 others. J Biol Chem, 2013. Cited by 18 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. UV-triggered affinity capture identifies interactions between the Plasmodium falciparum multidrug resistance protein 1 (PfMDR1) and antimalarial agents in live parasitized cells. Papers, record 23754276. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23754276
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- UV-triggered affinity capture identifies interactions between the Plasmodium falciparum multidrug resistance protein 1 (PfMDR1) and antimalarial agents in live parasitized cells.
- PubMed
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Validation Study
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| ATP Binding Cassette Transporter, Subfamily B, Member 1 | Major topic |
| Antimalarials | Major topic |
| Plasmodium falciparum | Major topic |
| Ultraviolet Rays | Major topic |
| Animals |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI056312 | NIAID NIH HHS | United States | R01AI056312 | PubMed and NIH | NIH RePORTER |
| R01 AI079709 | NIAID NIH HHS | United States | R01AI079709 | PubMed and NIH | NIH RePORTER |
| T32 GM007288 | NIGMS NIH HHS | United States | T32GM007288 | PubMed and NIH | NIH RePORTER |
| T32-GM007288 | NIGMS NIH HHS | United States | T32GM007288 | PubMed and NIH | NIH RePORTER |
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17638538 | Capture compound mass spectrometry: a technology for the investigation of small molecule protein interactions. | Assay Drug Dev Technol | 2007 | https://conductscience.org/library/papers/17638538 | PubMed |
| 2 | 20208550 | Artemisinin resistance: current status and scenarios for containment. | Nat Rev Microbiol | 2010 | https://conductscience.org/library/papers/20208550 | PubMed |
| 3 | 18439351 | Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border. | Emerg Infect Dis | 2008 | https://conductscience.org/library/papers/18439351 | PubMed |
| 4 | 22484134 | Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. | Lancet | 2012 | https://conductscience.org/library/papers/22484134 | PubMed |
| 5 | 22543 | Calf liver nuclear N-acetyltransferases. Purification and properties of two enzymes with both spermidine acetyltransferase and histone acetyltransferase activities. | J Biol Chem | 1978 | https://conductscience.org/library/papers/22543 | PubMed |
| 6 | 21300861 | Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21300861 | PubMed |
| 7 | 17346175 | Nucleoside transport as a potential target for chemotherapy in malaria. | Curr Pharm Des | 2007 | https://conductscience.org/library/papers/17346175 | PubMed |
| 8 | 10861212 | Identification of a nucleoside/nucleobase transporter from Plasmodium falciparum, a novel target for anti-malarial chemotherapy. | Biochem J | 2000 | https://conductscience.org/library/papers/10861212 | PubMed |
| 9 | 18669520 | In vitro assessment of the pharmacodynamic properties of DB75, piperaquine, OZ277 and OZ401 in cultures of Plasmodium falciparum. | J Antimicrob Chemother | 2008 | https://conductscience.org/library/papers/18669520 | PubMed |
| 10 | 18567789 | Purine salvage pathways in the intraerythrocytic malaria parasite Plasmodium falciparum. | Eukaryot Cell | 2008 | https://conductscience.org/library/papers/18567789 | PubMed |
| 11 | 21696174 | Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potential. | J Med Chem | 2011 | https://conductscience.org/library/papers/21696174 | PubMed |
| 12 | 394674 | Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/394674 | PubMed |
| 13 | 22096101 | Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery. | Science | 2011 | https://conductscience.org/library/papers/22096101 | PubMed |
| 14 | 24226387 | An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. | J Am Soc Mass Spectrom | 1994 | https://conductscience.org/library/papers/24226387 | PubMed |
| 15 | 22670848 | Malaria parasite type 4 equilibrative nucleoside transporters (ENT4) are purine transporters with distinct substrate specificity. | Biochem J | 2012 | https://conductscience.org/library/papers/22670848 | PubMed |
| 16 | 22732921 | Identification of a new chemical class of antimalarials. | J Infect Dis | 2012 | https://conductscience.org/library/papers/22732921 | PubMed |
| 17 | 19690537 | Target profiling of small molecules by chemical proteomics. | Nat Chem Biol | 2009 | https://conductscience.org/library/papers/19690537 | PubMed |
| 18 | 17917669 | Target deconvolution strategies in drug discovery. | Nat Rev Drug Discov | 2007 | https://conductscience.org/library/papers/17917669 | PubMed |
| 19 | 18621424 | A role for membrane potential in regulating GPCRs? | Trends Pharmacol Sci | 2008 | https://conductscience.org/library/papers/18621424 | PubMed |
| 20 | 20546803 | Purified Plasmodium falciparum multi-drug resistance protein (PfMDR 1) binds a high affinity chloroquine analogue. | Mol Biochem Parasitol | 2010 | https://conductscience.org/library/papers/20546803 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42203772 | Structural and mechanistic insights into the inhibition of Plasmodium falciparum MDR1. | Nat Commun | 2026 | https://conductscience.org/library/papers/42203772 | PubMed |
| 39861091 | Uncovering the Mechanism of Action of Antiprotozoal Agents: A Survey on Photoaffinity Labeling Strategy. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/39861091 | PubMed |
| 39808111 | Stereospecific Resistance to N2-Acyl Tetrahydro-β-carboline Antimalarials Is Mediated by a PfMDR1 Mutation That Confers Collateral Drug Sensitivity. | ACS Infect Dis | 2025 | https://conductscience.org/library/papers/39808111 | PubMed |
| 37232495 | Chemo-proteomics in antimalarial target identification and engagement. | Med Res Rev | 2023 | https://conductscience.org/library/papers/37232495 | PubMed |
| 34765267 | Protecting future antimalarials from the trap of resistance: Lessons from artemisinin-based combination therapy (ACT) failures. | J Pharm Anal | 2021 | https://conductscience.org/library/papers/34765267 | PubMed |
| 33570245 | Chemical Biology Tools To Investigate Malaria Parasites. | Chembiochem | 2021 | https://conductscience.org/library/papers/33570245 | PubMed |
| 30108934 | Recent updates in the discovery and development of novel antimalarial drug candidates. | Medchemcomm | 2018 | https://conductscience.org/library/papers/30108934 | PubMed |
| 29637069 | Targeting Channels and Transporters in Protozoan Parasite Infections. | Front Chem | 2018 | https://conductscience.org/library/papers/29637069 | PubMed |
| 28808258 | Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activity. | Nat Microbiol | 2017 | https://conductscience.org/library/papers/28808258 | PubMed |
| 27701420 | Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling. | PLoS Med | 2016 | https://conductscience.org/library/papers/27701420 | PubMed |
| 27073104 | CRISPR-Cas9-modified pfmdr1 protects Plasmodium falciparum asexual blood stages and gametocytes against a class of piperazine-containing compounds but potentiates artemisinin-based combination therapy partner drugs. | Mol Microbiol | 2016 | https://conductscience.org/library/papers/27073104 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23754276
GET https://conductscience.org/api/papers/v1/23754276/authors?page=2